Who We Are

EpiSign™ Inc. is a group of scientists and researchers who developed the cutting-edge diagnostic test. We focus on the field of epigenetics to transform rare disease diagnoses by providing clearer answers for millions of people worldwide who are affected by these conditions.

Our innovative epigenomic diagnostic technology delivers a diagnosis that standard genetic testing can’t achieve so patients and their families can pursue specialized care.